New hope for Hard-to-Treat colorectal cancer: Virus-Based therapy joins chemo
Disease control
Recruiting now
This study tests whether adding a virus-based drug called pelareorep to standard chemotherapy (FOLFIRI plus bevacizumab) can shrink tumors better than chemo alone in people with a specific type of advanced colorectal cancer (RAS-mutated, MSS). About 60 adults whose cancer worsene…
Phase: PHASE2 • Sponsor: Oncolytics Biotech • Aim: Disease control
Last updated May 26, 2026 12:08 UTC